Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Bladder Cancer

  Free Subscription


Articles published in Int J Urol

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    March 2018
  1. MIYAZAKI J, Onozawa M, Takaoka E, Yano I, et al
    Bacillus Calmette-Guerin strain differences as the basis for immunotherapies against bladder cancer.
    Int J Urol. 2018 Mar 5. doi: 10.1111/iju.13538.
    PubMed     Text format     Abstract available


  2. TATSUGAMI K
    Editorial Comment to Prediction models for progression of non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2018;25:218-219.
    PubMed     Text format    


    February 2018
  3. OTTO W, van Rhijn BW, Breyer J, Bertz S, et al
    Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naive stage T1 high-grade urothelial bladder cancer.
    Int J Urol. 2018 Feb 22. doi: 10.1111/iju.13532.
    PubMed     Text format     Abstract available


    December 2017
  4. FUJII Y
    Prediction models for progression of non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2017 Dec 16. doi: 10.1111/iju.13509.
    PubMed     Text format     Abstract available


  5. OHNO Y
    Editorial Comment to High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
    Int J Urol. 2017 Dec 7. doi: 10.1111/iju.13506.
    PubMed     Text format    


    November 2017
  6. YANG X, Shi L, Yi C, Yang Y, et al
    Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
    Int J Urol. 2017 Nov 8. doi: 10.1111/iju.13486.
    PubMed     Text format     Abstract available


  7. TAN YG, Eu EWC, Huang HH, Lau WKO, et al
    High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer.
    Int J Urol. 2017 Nov 1. doi: 10.1111/iju.13480.
    PubMed     Text format     Abstract available


    July 2017
  8. SALUJA M, Gilling P
    Intravesical bacillus Calmette-Guerin instillation in non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2017 Jul 25. doi: 10.1111/iju.13410.
    PubMed     Text format     Abstract available


  9. KOBATAKE K, Hayashi T, Black PC, Goto K, et al
    Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 22. doi: 10.1111/iju.13389.
    PubMed     Text format     Abstract available


  10. NASELLI A
    Editorial Comment to Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 21. doi: 10.1111/iju.13402.
    PubMed     Text format    


    March 2017
  11. SHIMIZU F, Muto S, Taguri M, Ieda T, et al
    Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
    Int J Urol. 2017 Mar 9. doi: 10.1111/iju.13324.
    PubMed     Text format     Abstract available


    February 2017
  12. INOUE K
    5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer.
    Int J Urol. 2017;24:97-101.
    PubMed     Text format     Abstract available


    January 2017
  13. ALIMI Q, Verhoest G, Kammerer-Jacquet SF, Mathieu R, et al
    Response to Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2017 Jan 13. doi: 10.1111/iju.13290.
    PubMed     Text format    


  14. MATSUMURA N, Nakamura Y, Kohjimoto Y, Nishizawa S, et al
    Overexpression of ribonucleotide reductase subunit M1 protein predicts shorter survival in metastatic bladder cancer patients treated with gemcitabine-containing combination chemotherapy.
    Int J Urol. 2017 Jan 9. doi: 10.1111/iju.13274.
    PubMed     Text format     Abstract available


    December 2016
  15. ALEVIZOPOULOS A, Tyritzis S, Leotsakos I, Anastasopoulou I, et al
    Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.
    Int J Urol. 2016 Dec 22. doi: 10.1111/iju.13271.
    PubMed     Text format     Abstract available


  16. BESIROGLU H
    Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2016 Dec 1. doi: 10.1111/iju.13269.
    PubMed     Text format    


    November 2016
  17. REIS LO
    Editorial Comment to Orthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line.
    Int J Urol. 2016;23:963.
    PubMed     Text format    


    October 2016
  18. VIDAL A, Arnold N, Vartolomei MD, Kiss B, et al
    Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial.
    Int J Urol. 2016 Oct 21. doi: 10.1111/iju.13228.
    PubMed     Text format     Abstract available


  19. HERMANS TJ, van de Putte EE, Horenblas S, van Rhijn BW, et al
    Extended pelvic lymph node dissection at radical cystectomy for bladder cancer improves survival: Results of a nationwide population-based study.
    Int J Urol. 2016 Oct 4. doi: 10.1111/iju.13227.
    PubMed     Text format    


    September 2016
  20. MIYAKE M, Hori S, Morizawa Y, Tatsumi Y, et al
    Orthotopic mouse model of renal pelvic cancer using a human bladder cancer cell line.
    Int J Urol. 2016 Sep 7. doi: 10.1111/iju.13220.
    PubMed     Text format    


  21. CONTRERAS-SANZ A, Roberts ME, Seiler R, Black PC, et al
    Recent progress with next-generation biomarkers in muscle-invasive bladder cancer.
    Int J Urol. 2016 Sep 6. doi: 10.1111/iju.13193.
    PubMed     Text format     Abstract available


    July 2016
  22. YUASA T
    Editorial Comment to Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2016 Jul 31. doi: 10.1111/iju.13178.
    PubMed     Text format    


  23. NAKAI Y, Anai S, Tanaka N, Chihara Y, et al
    Insignificant role of bacillus Calmette-Guerin maintenance therapy after complete transurethral resection of bladder tumor for intermediate- and high-risk non-muscle-invasive bladder cancer: Results from a randomized trial.
    Int J Urol. 2016 Jul 15. doi: 10.1111/iju.13167.
    PubMed     Text format     Abstract available


  24. ALIMI Q, Verhoest G, Kammerer-Jacquet SF, Mathieu R, et al
    Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer.
    Int J Urol. 2016 Jul 15. doi: 10.1111/iju.13164.
    PubMed     Text format     Abstract available


  25. KUBOTA Y, Nakaigawa N
    Essential content of evidence-based clinical practice guidelines for bladder cancer: The Japanese Urological Association 2015 update.
    Int J Urol. 2016 Jul 3. doi: 10.1111/iju.13141.
    PubMed     Text format     Abstract available


    May 2016
  26. FUJITA K, Matsuzaki K
    Response to Editorial Comment to Is it necessary to carry out intraoperative retrograde upper urinary tract cytology examination in bladder cancer patients with normal upper urinary tract appearance and suspicious or positive voided urine cytology?
    Int J Urol. 2016 May 30. doi: 10.1111/iju.13132.
    PubMed     Text format    


  27. INAMOTO T, Azuma H
    Editorial Comment to Is it necessary to carry out intraoperative retrograde upper urinary tract cytology examination in bladder cancer patients with normal upper urinary tract appearance and suspicious or positive voided urine cytology?
    Int J Urol. 2016 May 6. doi: 10.1111/iju.13115.
    PubMed     Text format    


    April 2016
  28. MATSUZAKI K, Fujita K, Ujike T, Uemura M, et al
    Is it necessary to carry out intraoperative retrograde upper urinary tract cytology examination in bladder cancer patients with normal upper urinary tract appearance and suspicious or positive voided urine cytology?
    Int J Urol. 2016 Apr 8. doi: 10.1111/iju.13100.
    PubMed     Text format    


  29. DAL MORO F, Zattoni F
    Lighting from the urethral cystoscope side: A novel technique to safely manage bowel division during intracorporeal robotic urinary diversion.
    Int J Urol. 2016;23:344-5.
    PubMed     Text format    


  30. JINZAKI M, Kikuchi E, Akita H, Sugiura H, et al
    Role of computed tomography urography in the clinical evaluation of upper tract urothelial carcinoma.
    Int J Urol. 2016;23:284-98.
    PubMed     Text format     Abstract available


    March 2016
  31. GOLABEK T, Bukowczan J
    Editorial Comment to Association between levels of urinary heavy metals and increased risk of urothelial carcinoma.
    Int J Urol. 2016;23:240.
    PubMed     Text format    


    February 2016
  32. WASHIO M
    Editorial Comment to Should patients newly diagnosed with bladder cancer be screened for lung cancer?
    Int J Urol. 2016 Feb 18. doi: 10.1111/iju.13064.
    PubMed     Text format    


    January 2016
  33. KRABBE LM, Lotan Y
    Should patients newly diagnosed with bladder cancer be screened for lung cancer?
    Int J Urol. 2016 Jan 14. doi: 10.1111/iju.13052.
    PubMed     Text format    


    December 2015
  34. YAGISAWA T, Okumi M, Omoto K, Sawada Y, et al
    Novel approach for bladder cancer treatment using sulfoquinovosylacylpropanediol as a radiosensitizer.
    Int J Urol. 2015 Dec 21. doi: 10.1111/iju.13034.
    PubMed     Text format    


    October 2015
  35. BALL MW
    Editorial Comment to Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
    Int J Urol. 2015 Oct 6. doi: 10.1111/iju.12964.
    PubMed     Text format    


  36. RICHARDS KA, Ham S, Cohn JA, Steinberg GD, et al
    Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
    Int J Urol. 2015 Oct 6. doi: 10.1111/iju.12959.
    PubMed     Text format     Abstract available


    August 2015
  37. OH JJ, Kang MY, Jo JK, Lee HM, et al
    Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy.
    Int J Urol. 2015 Aug 20. doi: 10.1111/iju.12901.
    PubMed     Text format     Abstract available


    June 2015
  38. KAUSHIK D, Frank I, Boorjian SA, Cheville JC, et al
    Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder.
    Int J Urol. 2015;22:549-54.
    PubMed     Text format     Abstract available


    May 2015
  39. GAUTHIER H, Culine S
    Editorial Comment to Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer.
    Int J Urol. 2015;22:495.
    PubMed     Text format    


  40. MUTO S, Abe H, Noguchi T, Sugiura S, et al
    Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer.
    Int J Urol. 2015;22:490-4.
    PubMed     Text format     Abstract available


    April 2015
  41. KANG M, Lee S, Jeong SJ, Hong SK, et al
    Characteristics and significant predictors of detecting underlying diseases in adults with asymptomatic microscopic hematuria: a large case series of a Korean population.
    Int J Urol. 2015;22:389-93.
    PubMed     Text format     Abstract available


    February 2015
  42. AKITA H, Okamura T, Nakane A, Kobayashi T, et al
    Infectious aortic aneurysms occurring 1 year after bacillus Calmette-Guerin bladder instillation therapy.
    Int J Urol. 2015;22:234-5.
    PubMed     Text format    


  43. GINORI A, Barone A, Santopietro R, Barbanti G, et al
    Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection.
    Int J Urol. 2015;22:222-5.
    PubMed     Text format     Abstract available


  44. BERMAN DM, Kawashima A, Peng Y, Mackillop WJ, et al
    Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:163-70.
    PubMed     Text format     Abstract available


  45. SHIGEHARA K, Namiki M
    Editorial comment to Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection.
    Int J Urol. 2015;22:225-6.
    PubMed     Text format    


  46. BERMAN DM, Kawashima A, Peng Y, Mackillop WJ, et al
    Response to editorial comments to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:172.
    PubMed     Text format    


  47. GONDO T
    Editorial comment from Dr Gondo to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:171.
    PubMed     Text format    


  48. TSUZUKI T
    Editorial comment from Dr Tsuzuki to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:170-1.
    PubMed     Text format    


    January 2015
  49. ROBINSON R
    Editorial Comment to Efficacy and tolerance of one-third full dose bacillus Calmette-Guerin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
    Int J Urol. 2015;22:61.
    PubMed     Text format    


  50. PFISTER C, Kerkeni W, Rigaud J, Le Gal S, et al
    Efficacy and tolerance of one-third full dose bacillus Calmette-Guerin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
    Int J Urol. 2015;22:53-60.
    PubMed     Text format     Abstract available


    September 2014
  51. ZAHRAN MH
    Response to Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:892-3.
    PubMed     Text format    


  52. EL-GAMAL OM
    Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:892.
    PubMed     Text format    


  53. ZAHRAN MH, El-Hefnawy AS, Zidan EM, El-Bilsha MA, et al
    Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:887-92.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: